DSpace university logo mark
詳細検索
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 050 薬学部 > 050 学術雑誌論文 >

Delivery advantage to the unilateral kidney by direct drug application to the kidney surface in rats and pharmacokinetic verification based on a physiological model


ファイル 記述 サイズフォーマット
JDT13_215.pdf83.2 kBAdobe PDF本文ファイル
JDT13_215_fig1.pdffigure111.79 kBAdobe PDF本文ファイル
JDT13_215_fig2-6.pdffigure2-632.5 kBAdobe PDF本文ファイル

タイトル: Delivery advantage to the unilateral kidney by direct drug application to the kidney surface in rats and pharmacokinetic verification based on a physiological model
著者: Nishida, Koyo / Kamenosono, Manabu / Kuma, Akiko / Fumoto, Shintaro / Mukai, Takahiro / Nakashima, Mikiro / Sasaki, Hitoshi / Nakamura, Junzo
発行日: 2005年 5月
出版者: Taylor & Francis
引用: Journal of Drug Targeting, 13 (4), 215-223, 2005
抄録: The objective of this study was to evaluate the drug delivery advantage to the unilateral kidney by direct drug application to the rat kidney surface based on a physiological pharmacokinetic model. Under anesthesia, a cylindrical diffusion cell (i.d. 6 mm, area 0.28 cm(2)) was attached to the right kidney surface in rats. Phenolsulfonphthalein (PSP), an organic anion chosen as a model compound, was added into the diffusion cell. The free PSP concentration in the right (applied) kidney after application to the right kidney surface at a dose of 1 mg was significantly higher than that of the left (non-applied) kidney until 60 min after application. Similarly, the urinary excretion rate of free PSP from the applied kidney was much faster than that from the non-applied kidney, with a 2.6 times larger excreted amount in 240 min. These results imply the possibility that a considerable drug delivery advantage to the unilateral kidney could be obtained after direct absorption from the kidney surface. This tendency was also observed at the other application doses of 0.3 and 1.5 mg. On the other hand, fluorescein isothiocyanate dextran (Mw 4400, FD-4) was equally excreted into the urine from each kidney and the renal concentrations in the applied and non-applied kidneys were almost the same, possibly due to the involvement of passive transport for the absorbed FD-4, i.e. glomerular filtration. The computer simulations of free PSP concentrations in the plasma and each kidney based on a physiological model after kidney surface application were consistent with the respective experimental data. Moreover, the delivery advantage of kidney surface application of PSP was verified by its comparison with other routes such as i.v. and i.a. administrations.
キーワード: Kidney surface / targeting / unilateral delivery / physiological model / pharmacokinetics
URI: http://hdl.handle.net/10069/6488
ISSN: 1061186X
DOI: 10.1080/10611860500159097
PubMed ID: 16051533
関連リンク : http://dx.doi.org/10.1080/10611860500159097
権利: This is an electronic version of an article published in J Drug Target. 2005 May13(4):215-23. the Journal of Drug Targeting is available online at: http://taylorandfrancis.metapress.com/openurl.asp?genre=article&id=doi:10.1080/10611860500159097.
資料タイプ: Journal Article
原稿種類: author
出現コレクション:050 学術雑誌論文

引用URI : http://hdl.handle.net/10069/6488

このリポジトリに保管されている文献はすべて著作権により保護されています。
印刷やダウンロード等データの複製は、調査研究・教育または学習を目的とする場合に限定されます。

 

Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace